Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
Clinical trial NCT02392039 · TERMINATED
Trial details
- NCT number
- NCT02392039
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-14
- Primary completion
- 2018-04-04
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.